Neurotrophic factors in the pathogenesis of Rett syndrome

Journal of Child Neurology

Volumn 18, Issue 10, 2003, Pages 693-697

  Riikonen, Raili ^a  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTAMIC ACID; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; BRAIN METABOLISM; CELL MATURATION; CEREBELLUM; CEREBROSPINAL FLUID ANALYSIS; CHILD; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOREBRAIN; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HUMAN; INFANT; INFANTILE AUTISM; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; RETT SYNDROME;

EID: 0242624585     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738030180101101     Document Type: Article

References (42)

1. Armstrong D, Dunn J, Antalffy B, Trivedi R: Selective dendritic alterations in the cortex of Rett syndrome. J Neuropathol Exp Neurol 1995;54:195-201.
2. Percy A: Neurobiology and neurochemistry of Rett syndrome. Eur Child Adolesc Psychiatry 1997;6:80-82.
3. Belincho P, Hagberg B: Morphological study of neocortical areas in Rett syndrome. Acta Neuropathol (Berl) 1997;93:50-61.
4. Johnston M, Jeon O, Pevsner J, et al: Neurobiology of Rett syndrome: A genetic disorder of synapse development. Brain Dev 2001;23(Suppl 1):S206-S213.
5. Ebendal T: Function and evolution in the NGF family and its receptors. J Neurosci Res 1992;32:461-470.
6. Sofroniew M, Cooper J: Neurotrophic mechanisms and neuronal degeneration. Neuroscience 1993;5:285-294.
7. Auranen M, Vanhala R, Vosman M, et al: MECP2 gene analysis in classical Rett syndrome and in patients with Rett-like features. Neurology 2001;56:611-617.
8. Lappalainen R, Lindholm D, Riikonen R: Low levels of nerve growth factor in cerebrospinal fluid of children with Rett syndrome. J Child Neurol 1996;11:296-300.
9. Riikonen R, Vanhala R: Levels of cerebrospinal nerve-growth factor differ in infantile autism and Rett syndrome. Dev Med Child Neurol 1999;41:148-152.
10. Gillberg C, Coleman M: Autism and medical disorders: A review of the literature. Dev Med Child Neurol 1996;38:191-202.
11. Lappalainen R, Riikonen R: High levels of cerebrospinal fluid glutamate in Rett syndrome. Pediatr Neurol 1996;15:213-216.
12. Vanhala R, Korhonen L, Mikelsaar M, et al: Neurotrophic factors in cerebrospinal fluid of patients with Rett syndrome. J Child Neurol 1998;13:429-433.
13. Vanhala R, Turpeinen U, Riikonen R: Low levels of insulin-like growth factor in cerebrospinal fluid in children with autism. Dev Med Child Neurol 2001;43:614-616.
14. Hohmann C, Brooks A, Coyle J: Neonatal lesions of the basal forebrain cholinergic neurons result in abnormal cortical development. Dev Brain Res 1988;43:253-264.
15. Armstrong D, Dunn J, Schultz R, et al: Organ growth in Rett syndrome; a postmortem examination and analysis. Pediatr Neurol 1999;20:125-129.
16. Raymond G, Bauman M, Kemper T: Hippocampus in autism: A Golgi analysis. Acta Neuropathol (Berl) 1996;91:117-119.
17. Wenk GL, Hauss-Wegrzyniak B: Altered cholinergic function in the basal forebrain of girls with Rett syndrome. Neuropediatrics 1999;30:125-129.
18. Lipani JD, Bhattacharjee MB, Corey DM, Lee DA: Reduced nerve growth factor in Rett syndrome postmortem brain tissue. J Neuropathol Exp Neurol 2000;59:889-895.
19. Uvebrandt P, Bjure J, Sixt R, et al: Regional cerebral blood flow: SPECT as a tool for localization of brain dysfunction, in Hagberg B (ed): Rett Syndrome - Clinical and Biological Aspects. London, Mac Keith Press, 1993, 80-85.
20. Lappalainen R, Liewendahl K, Sainio K, Riikonen R: Brain perfusion SPECT and EEG findings in Rett syndrome. Acta Paediatr Scand 1997;95:44-50.
21. Leventhal P, Russell J, Feldman E: IgFs and the nervous system, in Rosenfeld R, Roberts C (eds): The IGF System: Molecular Biology, Physiology, and Clinical Application. Totawa, NJ, Humana Press, 1999, 425-455.
22. Torres-Aleman I, Poins S, Santos-Benito F: Survival of Purkinje cells in cerebellar cultures increased by insulin-like growth factor-1. Eur J Neurosci 1992;4:864-869.
23. Torres-Aleman I, Barrios V, Lledo A, Berciano J: The insulin-like growth factor-1 modulation of cerebellar cell populations is developmentally stage-dependent and mediated by specific intracellular pathways. Neuroscience 1998;83:321-334.
24. Gao W, Heintz N, Hatten M: Cerebellar granule neurogenesis is regulated by cell-cell interaction in vitro. Neuron 1991;6:705-715.
25. Courchesne E, Yeung-Courchesne R, Press GA, et al: Hypoplasia of cerebellar vermal lobules VI and VII in autism. N Engl J Med 1988;318:1349-1354.
26. Hashimoto T, Tayama M, Murakawa E, et al: Development of brainstem and cerebellum in autistic patients. J Autism Dev Disord 1995;25:1-18.
27. Rapin I, Katzman R: Neurobiology of autism. Ann Neurol 1998;43:7-14.
28. Bauman M, Kemper T: Histoanatomic observations of the brain in early infantile autism. Neurology 1985;35:862-866.
29. Riikonen R, Somer M, Turpeinen U: Low insulin-like growth factor (IGF-1) in the cerebrospinal fluid of children with PEHO syndrome (progressive encephalopathy, hypsarrhythmia and optic atrophy) and cerebellar degeneration. Epilepsia 1999;40: 1642-1648.
30. Davidovitch M, Patterson B, Gartside P: Head circumference measurements in children with autism. J Child Neurol 1996; 11:389-393.
31. Sparks B, Friedman S, Shaw D, et al: Brain structural abnormalities in young children with autism spectrum disorder. Neurology 2002;59:184-192.
32. Coleman P, Romano J, Lapham I, Simon W: Cell counts in cerebral cortex in autistic patient. J Autism Dev Disord 1985;15: 245-255.
33. Anderson G, Freedman D, Cohen D, et al: Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry 1987;28:885-900.
34. Chugani H, Muzik O, Rothermel R, et al: Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann Neurol 1997;42:666-669.
35. Cook E, Courchesne R, Lord C, et al: Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry 1997;2:247-250.
36. Rodier P, Ingram J, Tisdale B, et al: Embryological origin for autism; developmental anomalies of the cranial nerve motor nuclei. J Comp Neurol 1996;370:247-261.
37. Monaghan D, Bridges R, Cotman C: The excitatory amino acid receptors. Annu Rev Pharmacol Toxicol 1989;29:365-402.
38. Rothman S, Olney J: Excitotoxicity and NMDA receptor. Trends Neurosci 1987;10:299-302.
39. Ikonomidou C, Turski L: Excitotoxicity and neurodegenerative diseases. Curr Opin Neurol 1995;8:487-497.
40. Lindholm D: Role of neurotrophins in preventing glutamate induced neuronal cell death. J Neurol 1994;24(Suppl 1):S16-S18.
41. Riikonen R, Korhonen L, Lindholm D: Cerebrospinal fluid growth factor - A marker of asphyxia? Pediatr Neurol 1999;20:137-141.
42. Riikonen R, Söderström S, Vanhala R, et al: West syndrome: Cerebrospinal fluid nerve growth factor and effect of ACTH. Pediatr Neurol 1997;17:224-229.